Logo of Oncosil Medical (ASX:OSL)Latest Oncosil Medical (ASX:OSL) News

Page 6
Page 6 of 6

OncoSil Medical Expands Global Reach and Boosts Cash Reserves in Q2 FY25

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.
Victor Sage
30 Jan 2025

OncoSil Medical Secures MDR Approval, Unlocking EU Market Potential

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.
Victor Sage
28 Jan 2025